RET and non-small cell lung adenocarcinoma: RET gene positivity in non-small cell lung adenocarcinoma is approximately 1% to 2%, RET fusion mutations and some other genetic mutations (eg, EGFR receptor mutations, ALK gene rearrangements) are mutually exclusive (42).